Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.280
-0.050 (-3.76%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Pulmatrix Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
4.67M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 60 Degrees Pharmaceuticals | 1.41M |
| SciSparc | 1.31M |
| Bio Green Med Solution | 747.00K |
| VivoSim Labs | 142.00K |
| AIM ImmunoTech | 88.00K |
| Cardio Diagnostics Holdings | 14.83K |
| Azitra | 7.50K |
| Soligenix | 2.34K |
PULM News
- 7 days ago - Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger - PRNewsWire
- 4 weeks ago - Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan - PRNewsWire
- 2 months ago - Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities - PRNewsWire
- 2 months ago - Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results - PRNewsWire
- 4 months ago - Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives - PRNewsWire
- 6 months ago - Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - PRNewsWire
- 9 months ago - Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets - PRNewsWire
- 1 year ago - Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets - PRNewsWire